---
title: "Neutrophils' Bidirectional Regulation of Bone Metabolism: Mechanisms and Contextual Effects"
id: "frontiers-in-immunology-8-the-bidirectional-role-of-neutrophils-in-the-regulation-of-bone-metabolism-a"
canonical_url: "https://medichelpline.com/clinical-feed/frontiers-in-immunology-8-the-bidirectional-role-of-neutrophils-in-the-regulation-of-bone-metabolism-a"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "Frontiers in Immunology"
source_url: "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1868073"
published_at: "2026-10-01T00:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Neutrophils' Bidirectional Regulation of Bone Metabolism: Mechanisms and Contextual Effects
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/frontiers-in-immunology-8-the-bidirectional-role-of-neutrophils-in-the-regulation-of-bone-metabolism-a
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** Frontiers in Immunology
- **Source URL:** [Original Journal Publication](https://www.frontiersin.org/articles/10.3389/fimmu.2026.1868073)
- **Published At:** 2026-10-01T00:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- Neutrophils, the most abundant innate immune cells in bone marrow, influence bone homeostasis by affecting both **osteogenesis** and **osteoclastogenesis**. They act through phagocytosis, degranulation, cytokine release, reactive oxygen species (ROS), and neutrophil extracellular traps (NETs). - During early bone repair, neutrophils can support regeneration by clearing necrotic debris, promoting angiogenesis, and modulating mesenchymal stem cell (MSC) function, thereby establishing a pro-regenerative microenvironment. - In pathological states such as persistent inflammation, metabolic dysfunction, tumor-associated bone disease, and aging, dysregulated neutrophils may suppress osteogenesis and enhance bone resorption via inflammatory mediators (TNF-α, IL-1β, IL-6, IL-8), MMP9, ROS, and NETs. - NETs have context-dependent, bidirectional effects on bone remodeling: they may either aid repair or exacerbate bone destruction depending on local microenvironment and disease context. - Neutrophil heterogeneity arises from developmental stage, cellular age, tissue localization, circadian regulation, and microenvironmental cues; emergency granulopoiesis increases heterogeneity by releasing immature neutrophils into circulation. - Functional neutrophil states are best described as dynamic programs (pro-inflammatory “N1-like” and pro-resolving “N2-like”) rather than fixed subsets; these states determine neutrophil roles in host defense, inflammation amplification, resolution, and tissue repair. - Aging and chronic conditions remodel neutrophil effector functions (e.g., altered MPO content, NET capacity), contributing to shifts in bone immune regulation. - A state-based view of neutrophil behavior is particularly relevant to the bone microenvironment, where neutrophils can exert diverse and sometimes opposing effects on osteoblasts, osteoclasts, and bone remodeling depending on activation status and local cues. - Systematic elucidation of neutrophil mechanisms in bone metabolism could inform therapeutic strategies for osteoporosis, impaired fracture healing, and inflammatory bone destruction. Specific mechanistic and therapeutic details beyond the review scope were not reported in the provided source text.
## Clinical Analysis & Structured Key Points
[](https://www.frontiersin.org/) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1868073/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) About us About us * Who we are * [Mission and values](https://www.frontiersin.org/about/mission) * [History](https://www.frontiersin.org/about/history) * [Leadership](https://www.frontiersin.org/about/leadership) * [Awards](https://www.frontiersin.org/about/awards) * Impact and progress * [Frontiers' impact](https://www.frontiersin.org/about/impact) * [Our annual reports](https://www.frontiersin.org/about/annual-reports) * [Thought leadership](https://www.frontiersin.org/about/thought-leadership) * [Researcher perspectives](https://www.frontiersin.org/about/researcher-perspectives) * Publishing model * [How we publish](https://www.frontiersin.org/about/how-we-publish) * [Open access](https://www.frontiersin.org/about/open-access) * [Quality and research integrity](https://www.frontiersin.org/about/quality) * [Peer review](https://www.frontiersin.org/about/peer-review) * [Technology and platforms](https://www.frontiersin.org/about/technology-and-platforms) * [Research Topics](https://www.frontiersin.org/about/research-topics) * [Publish your data with FAIR²](https://www.frontiersin.org/about/fair-data-management) * [Fee policy](https://www.frontiersin.org/about/fee-policy) * Services * [Societies](https://publishingpartnerships.frontiersin.org/) * [National consortia](https://www.frontiersin.org/open-access-agreements/consortia) * [Institutional partnerships](https://www.frontiersin.org/about/open-access-agreements) * [Collaboration and indexation](https://www.frontiersin.org/about/collaboration-indexation) * More from Frontiers * [Frontiers Forum](https://forum.frontiersin.org/) * [Frontiers Planet Prize](https://www.frontiersin.org/about/frontiers-planet-prize) * [Press office](https://pressoffice.frontiersin.org/) * [Sustainability](https://www.frontiersin.org/about/sustainability) * [Career opportunities](https://careers.frontiersin.org/) * [Contact us](https://www.frontiersin.org/about/contact) [All journals](https://www.frontiersin.org/journals)[All articles](https://www.frontiersin.org/articles) [Submit manuscript](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276) [Search](https://www.frontiersin.org/search?tab=top-results&origin=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fimmunology%2Farticles%2F10.3389%2Ffimmu.2026.1868073%2Ffull)[Login](https://www.frontiersin.org/people/login?returnUrl=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fimmunology%2Farticles%2F10.3389%2Ffimmu.2026.1868073%2Ffull) [](https://www.frontiersin.org/) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1868073/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) Sections Sections * [Alloimmunity and Transplantation](https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation) * [Autoimmune Disorders](https://www.frontiersin.org/journals/immunology/sections/autoimmune-disorders) * [Autoinflammatory Disorders](https://www.frontiersin.org/journals/immunology/sections/autoinflammatory-disorders) * [B Cell Biology](https://www.frontiersin.org/journals/immunology/sections/b-cell-biology) * [Cancer Immunity and Immunotherapy](https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy) * [Comparative Immunology](https://www.frontiersin.org/journals/immunology/sections/comparative-immunology) * [Cytokines and Soluble Mediators in Immunity](https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity) * [Dendritic Cells, Macrophages and APC Immunology](https://www.frontiersin.org/journals/immunology/sections/dendritic-cells-macrophages-and-apc-immunology) * [Immunological Memory](https://www.frontiersin.org/journals/immunology/sections/immunological-memory) * [Immunological Tolerance and Regulation](https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation) * [Inflammation](https://www.frontiersin.org/journals/immunology/sections/inflammation) * [Methods and New Technologies in Immunology](https://www.frontiersin.org/journals/immunology/sections/methods-and-new-technologies-in-immunology) * [Microbial Immunology](https://www.frontiersin.org/journals/immunology/sections/microbial-immunology) * [Molecular Innate Immunity](https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity) * [Mucosal Immunity](https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity) * [Multiple Sclerosis and Neuroimmunology](https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology) * [NK and Innate Lymphoid Cell Biology](https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology) * [Nutritional Immunology](https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology) * [Parasite Immunology](https://www.frontiersin.org/journals/immunology/sections/parasite-immunology) * [Primary Immunodeficiencies](https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies) * [Sex Differences in Immunology](https://www.frontiersin.org/journals/immunology/sections/sex-differences-in-immunology) * [Systems Immunology](https://www.frontiersin.org/journals/immunology/sections/systems-immunology) * [T Cell Biology](https://www.frontiersin.org/journals/immunology/sections/t-cell-biology) * [Vaccines and Molecular Therapeutics](https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics) * [Viral Immunology](https://www.frontiersin.org/journals/immunology/sections/viral-immunology) [Articles](https://www.frontiersin.org/journals/immunology/articles)[Research Topics](https://www.frontiersin.org/journals/immunology/research-topics)[Editorial board](https://www.frontiersin.org/journals/immunology/editors) About journal About journal * Scope * [Field chief editors](https://www.frontiersin.org/journals/immunology/about#about-editors) * [Mission and scope](https://www.frontiersin.org/journals/immunology/about#about-scope) * [Facts](https://www.frontiersin.org/journals/immunology/about#about-facts) * [Journal sections](https://www.frontiersin.org/journals/immunology/about#about-submission) * [Open access statement](https://www.frontiersin.org/journals/immunology/about#about-open) * [Copyright statement](https://www.frontiersin.org/journals/immunology/about#copyright-statement) * [Quality](https://www.frontiersin.org/journals/immunology/about#about-quality) * For authors * [Why submit?](https://www.frontiersin.org/journals/immunology/for-authors/why-submit) * [Article types](https://www.frontiersin.org/journals/immunology/for-authors/article-types) * [Author guidelines](https://www.frontiersin.org/journals/immunology/for-authors/author-guidelines) * [Editor guidelines](https://www.frontiersin.org/journals/immunology/for-authors/editor-guidelines) * [Publishing fees](https://www.frontiersin.org/journals/immunology/for-authors/publishing-fees) * [Submission checklist](https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist) * [Contact editorial office](https://www.frontiersin.org/journals/immunology/for-authors/contact-editorial-office) About us About us * Who we are * [Mission and values](https://www.frontiersin.org/about/mission) * [History](https://www.frontiersin.org/about/history) * [Leadership](https://www.frontiersin.org/about/leadership) * [Awards](https://www.frontiersin.org/about/awards) * Impact and progress * [Frontiers' impact](https://www.frontiersin.org/about/impact) * [Our annual reports](https://www.frontiersin.org/about/annual-reports) * [Thought leadership](https://www.frontiersin.org/about/thought-leadership) * [Researcher perspectives](https://www.frontiersin.org/about/researcher-perspectives) * Publishing model * [How we publish](https://www.frontiersin.org/about/how-we-publish) * [Open access](https://www.frontiersin.org/about/open-access) * [Quality and research integrity](https://www.frontiersin.org/about/quality) * [Peer review](https://www.frontiersin.org/about/peer-review) * [Technology and platforms](https://www.frontiersin.org/about/technology-and-platforms) * [Research Topics](https://www.frontiersin.org/about/research-topics) * [Publish your data with FAIR²](https://www.frontiersin.org/about/fair-data-management) * [Fee policy](https://www.frontiersin.org/about/fee-policy) * Services * [Societies](https://publishingpartnerships.frontiersin.org/) * [National consortia](https://www.frontiersin.org/open-access-agreements/consortia) * [Institutional partnerships](https://www.frontiersin.org/about/open-access-agreements) * [Collaboration and indexation](https://www.frontiersin.org/about/collaboration-indexation) * More from Frontiers * [Frontiers Forum](https://forum.frontiersin.org/) * [Frontiers Planet Prize](https://www.frontiersin.org/about/frontiers-planet-prize) * [Press office](https://pressoffice.frontiersin.org/) * [Sustainability](https://www.frontiersin.org/about/sustainability) * [Career opportunities](https://careers.frontiersin.org/) * [Contact us](https://www.frontiersin.org/about/contact) [All journals](https://www.frontiersin.org/journals)[All articles](https://www.frontiersin.org/articles) [Submit manuscript](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1868073/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) Sections Sections * [Alloimmunity and Transplantation](https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation) * [Autoimmune Disorders](https://www.frontiersin.org/journals/immunology/sections/autoimmune-disorders) * [Autoinflammatory Disorders](https://www.frontiersin.org/journals/immunology/sections/autoinflammatory-disorders) * [B Cell Biology](https://www.frontiersin.org/journals/immunology/sections/b-cell-biology) * [Cancer Immunity and Immunotherapy](https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy) * [Comparative Immunology](https://www.frontiersin.org/journals/immunology/sections/comparative-immunology) * [Cytokines and Soluble Mediators in Immunity](https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity) * [Dendritic Cells, Macrophages and APC Immunology](https://www.frontiersin.org/journals/immunology/sections/dendritic-cells-macrophages-and-apc-immunology) * [Immunological Memory](https://www.frontiersin.org/journals/immunology/sections/immunological-memory) * [Immunological Tolerance and Regulation](https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation) * [Inflammation](https://www.frontiersin.org/journals/immunology/sections/inflammation) * [Methods and New Technologies in Immunology](https://www.frontiersin.org/journals/immunology/sections/methods-and-new-technologies-in-immunology) * [Microbial Immunology](https://www.frontiersin.org/journals/immunology/sections/microbial-immunology) * [Molecular Innate Immunity](https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity) * [Mucosal Immunity](https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity) * [Multiple Sclerosis and Neuroimmunology](https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology) * [NK and Innate Lymphoid Cell Biology](https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology) * [Nutritional Immunology](https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology) * [Parasite Immunology](https://www.frontiersin.org/journals/immunology/sections/parasite-immunology) * [Primary Immunodeficiencies](https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies) * [Sex Differences in Immunology](https://www.frontiersin.org/journals/immunology/sections/sex-differences-in-immunology) * [Systems Immunology](https://www.frontiersin.org/journals/immunology/sections/systems-immunology) * [T Cell Biology](https://www.frontiersin.org/journals/immunology/sections/t-cell-biology) * [Vaccines and Molecular Therapeutics](https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics) * [Viral Immunology](https://www.frontiersin.org/journals/immunology/sections/viral-immunology) [Articles](https://www.frontiersin.org/journals/immunology/articles)[Research Topics](https://www.frontiersin.org/journals/immunology/research-topics)[Editorial board](https://www.frontiersin.org/journals/immunology/editors) About journal About journal * Scope * [Field chief editors](https://www.frontiersin.org/journals/immunology/about#about-editors) * [Mission and scope](https://www.frontiersin.org/journals/immunology/about#about-scope) * [Facts](https://www.frontiersin.org/journals/immunology/about#about-facts) * [Journal sections](https://www.frontiersin.org/journals/immunology/about#about-submission) * [Open access statement](https://www.frontiersin.org/journals/immunology/about#about-open) * [Copyright statement](https://www.frontiersin.org/journals/immunology/about#copyright-statement) * [Quality](https://www.frontiersin.org/journals/immunology/about#about-quality) * For authors * [Why submit?](https://www.frontiersin.org/journals/immunology/for-authors/why-submit) * [Article types](https://www.frontiersin.org/journals/immunology/for-authors/article-types) * [Author guidelines](https://www.frontiersin.org/journals/immunology/for-authors/author-guidelines) * [Editor guidelines](https://www.frontiersin.org/journals/immunology/for-authors/editor-guidelines) * [Publishing fees](https://www.frontiersin.org/journals/immunology/for-authors/publishing-fees) * [Submission checklist](https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist) * [Contact editorial office](https://www.frontiersin.org/journals/immunology/for-authors/contact-editorial-office) [](https://www.frontiersin.org/) [ ![](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1868073/full) Frontiers in Immunology ](https://www.frontiersin.org/journals/immunology) Sections Sections * [Alloimmunity and Transplantation](https://www.frontiersin.org/journals/immunology/sections/alloimmunity-and-transplantation) * [Autoimmune Disorders](https://www.frontiersin.org/journals/immunology/sections/autoimmune-disorders) * [Autoinflammatory Disorders](https://www.frontiersin.org/journals/immunology/sections/autoinflammatory-disorders) * [B Cell Biology](https://www.frontiersin.org/journals/immunology/sections/b-cell-biology) * [Cancer Immunity and Immunotherapy](https://www.frontiersin.org/journals/immunology/sections/cancer-immunity-and-immunotherapy) * [Comparative Immunology](https://www.frontiersin.org/journals/immunology/sections/comparative-immunology) * [Cytokines and Soluble Mediators in Immunity](https://www.frontiersin.org/journals/immunology/sections/cytokines-and-soluble-mediators-in-immunity) * [Dendritic Cells, Macrophages and APC Immunology](https://www.frontiersin.org/journals/immunology/sections/dendritic-cells-macrophages-and-apc-immunology) * [Immunological Memory](https://www.frontiersin.org/journals/immunology/sections/immunological-memory) * [Immunological Tolerance and Regulation](https://www.frontiersin.org/journals/immunology/sections/immunological-tolerance-and-regulation) * [Inflammation](https://www.frontiersin.org/journals/immunology/sections/inflammation) * [Methods and New Technologies in Immunology](https://www.frontiersin.org/journals/immunology/sections/methods-and-new-technologies-in-immunology) * [Microbial Immunology](https://www.frontiersin.org/journals/immunology/sections/microbial-immunology) * [Molecular Innate Immunity](https://www.frontiersin.org/journals/immunology/sections/molecular-innate-immunity) * [Mucosal Immunity](https://www.frontiersin.org/journals/immunology/sections/mucosal-immunity) * [Multiple Sclerosis and Neuroimmunology](https://www.frontiersin.org/journals/immunology/sections/multiple-sclerosis-and-neuroimmunology) * [NK and Innate Lymphoid Cell Biology](https://www.frontiersin.org/journals/immunology/sections/nk-and-innate-lymphoid-cell-biology) * [Nutritional Immunology](https://www.frontiersin.org/journals/immunology/sections/nutritional-immunology) * [Parasite Immunology](https://www.frontiersin.org/journals/immunology/sections/parasite-immunology) * [Primary Immunodeficiencies](https://www.frontiersin.org/journals/immunology/sections/primary-immunodeficiencies) * [Sex Differences in Immunology](https://www.frontiersin.org/journals/immunology/sections/sex-differences-in-immunology) * [Systems Immunology](https://www.frontiersin.org/journals/immunology/sections/systems-immunology) * [T Cell Biology](https://www.frontiersin.org/journals/immunology/sections/t-cell-biology) * [Vaccines and Molecular Therapeutics](https://www.frontiersin.org/journals/immunology/sections/vaccines-and-molecular-therapeutics) * [Viral Immunology](https://www.frontiersin.org/journals/immunology/sections/viral-immunology) [Articles](https://www.frontiersin.org/journals/immunology/articles)[Research Topics](https://www.frontiersin.org/journals/immunology/research-topics)[Editorial board](https://www.frontiersin.org/journals/immunology/editors) About journal About journal * Scope * [Field chief editors](https://www.frontiersin.org/journals/immunology/about#about-editors) * [Mission and scope](https://www.frontiersin.org/journals/immunology/about#about-scope) * [Facts](https://www.frontiersin.org/journals/immunology/about#about-facts) * [Journal sections](https://www.frontiersin.org/journals/immunology/about#about-submission) * [Open access statement](https://www.frontiersin.org/journals/immunology/about#about-open) * [Copyright statement](https://www.frontiersin.org/journals/immunology/about#copyright-statement) * [Quality](https://www.frontiersin.org/journals/immunology/about#about-quality) * For authors * [Why submit?](https://www.frontiersin.org/journals/immunology/for-authors/why-submit) * [Article types](https://www.frontiersin.org/journals/immunology/for-authors/article-types) * [Author guidelines](https://www.frontiersin.org/journals/immunology/for-authors/author-guidelines) * [Editor guidelines](https://www.frontiersin.org/journals/immunology/for-authors/editor-guidelines) * [Publishing fees](https://www.frontiersin.org/journals/immunology/for-authors/publishing-fees) * [Submission checklist](https://www.frontiersin.org/journals/immunology/for-authors/submission-checklist) * [Contact editorial office](https://www.frontiersin.org/journals/immunology/for-authors/contact-editorial-office) [Submit manuscript](https://www.frontiersin.org/submission/submit?domainid=2&fieldid=35&specialtyid=0&entitytype=2&entityid=276) [Search](https://www.frontiersin.org/search?tab=top-results&origin=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fimmunology%2Farticles%2F10.3389%2Ffimmu.2026.1868073%2Ffull)[Login](https://www.frontiersin.org/people/login?returnUrl=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fimmunology%2Farticles%2F10.3389%2Ffimmu.2026.1868073%2Ffull) ## REVIEW article Front. Immunol., 01 Oc
## Related Clinical Research

- [Vitamin B5 derivative linked to reduced psoriasis plaques and inflammation in small trial](https://medichelpline.com/clinical-feed/medical-news-today-0-vitamin-b5-derivative-may-reduce-psoriasis-plaques-and-inflammation-small-trial.md)
- [Retatrutide: A New Approach for Easing Knee Osteoarthritis Pain](https://medichelpline.com/clinical-feed/medical-news-today-0-new-weight-loss-drug-eases-knee-osteoarthritis-pain-in-major-trials.md)
- [Herpesvirus Antibody Networks Linked to Autoimmunity and Chronic Disease](https://medichelpline.com/clinical-feed/nature-immunology-0-herpesvirus-exposures-map-to-self-reactivity-networks-in-chronic-disease.md)
- [Herpesvirus–autoantigen antibody networks linked to chronic disease in large biobank profiling](https://medichelpline.com/clinical-feed/nature-immunology-2-large-scale-antibody-reactome-profiling-identifies-herpesvirus-autoantigen.md)
- [Strain-specific and HIV-driven humoral responses to Epstein-Barr virus mapped by PhIP-Seq](https://medichelpline.com/clinical-feed/pubmed-42841646.md) (DOI: 10.1128/jvi.01043-26)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.